Benzinga | Jul 29, 2021 04:39PM EDT

Ekso Bionics Holdings Q2 EPS $(0.11) Beats $(0.25) Estimate, Sales $2.20M Beat $2.10M Estimate

Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.25) by 56 percent. This is a 94.02 percent increase over losses of $(1.84) per share from the same period last year. The company reported quarterly sales of $2.20 million which beat the analyst consensus estimate of $2.10 million by 4.76 percent. This is a 4.35 percent decrease over sales of $2.30 million the same period last year.